Brigida Anna Maiorano, Valentina Tateo, Antonio Cigliola, Chiara Mercinelli, Alberto Briganti, Francesco Montorsi, Andrea Necchi. "Perioperative enfortumab vedotin plus pembrolizumab versus neoadjuvant pembrolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC): An IPD-based comparative analysis of KEYNOTE-905/EV-303 and PURE-01.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.779